trending Market Intelligence /marketintelligence/en/news-insights/trending/khcbvQkllJEjwf7F7aEHmg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Heron to sell additional shares to underwriters in common stock offering

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates

Blog

COVID-19 Impact & Recovery: Investment Banking


Heron to sell additional shares to underwriters in common stock offering

Heron Therapeutics Inc. said underwriters in its common stock offering fully exercised their option to purchase an additional 1,845,000 common shares.

Total net proceeds, minus expenses and underwriting discounts and commissions, are now expected to total about $163.7 million.

The sale of the additional shares is expected to close Feb. 3.

BofA Merrill Lynch, Cowen and Co. LLC and Leerink Partners LLC are acting as joint book-running managers for the offering. Cantor Fitzgerald & Co. and JMP Securities LLC are acting as lead managers while Noble Capital Markets, LifeSci Capital, Aegis Capital Corp. and Lake Street Capital Markets are acting as co-managers for the offering.